Market Tracker

08/18 5:16pm ET

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

17.30
Delayed Data
As of 4:01pm ET
 +0.20 / +1.17%
Today’s Change
16.81
Today|||52-Week Range
53.96
-52.28%
Year-to-Date
Oversold Small-Cap Biotech Names
11:32am / TheStreet.com - Paid Partner Content
Teva Stock Tumbles Again, Citi Downgrades, Says 'We Have Been Wrong'
Aug 16 / TheStreet.com - Paid Partner Content
Valeant CEO Confident Divestitures Can Successfully Pare Debt, Skeptics Remain
Aug 17 / TheStreet.com - Paid Partner Content
Teva Blood Is in the Streets
Aug 16 / GuruFocus News - Paid Partner Content
PayPal, Marriott International, Randgold Resources: 'Mad Money' Lightning Round
Aug 16 / TheStreet.com - Paid Partner Content
Teva Is Cheap, Not Dead
Aug 16 / TheStreet.com - Paid Partner Content
Valeant Pharmaceuticals: Cramer's Top Takeaways
Aug 16 / TheStreet.com - Paid Partner Content
International Paper, Inogen, Teva Pharmaceuticals: 'Mad Money' Lightning Round
Aug 15 / TheStreet.com - Paid Partner Content
The Market Is Not About Washington: Cramer's 'Mad Money' Recap (Wed 8/16/17)
Aug 16 / TheStreet.com - Paid Partner Content
Francis Chou Buys More Valeant and Teva in 2nd Quarter
Aug 15 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close17.10
Today’s open17.14
Day’s range17.10 - 17.53
Volume9,160,275
Average volume (3 months)12,649,159
Market cap$17.3B
Dividend yield6.39%
Data as of 4:01pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-96.18%
Earnings growth (this year)-15.13%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+12.01%
P/E ratioNM
Price/Sales1.59
Price/Book0.58

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd-3.02-4.36%
TYMETyme Technologies In...+0.22+3.53%
OASMOasmia Pharmaceutica...+0.01+0.94%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)$1.10
Annual revenue (last year)$22.0B
Annual profit (last year)$330.0M
Net profit margin1.50%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President &
Chief Executive Officer
Yitzhak Peterburg
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Hamerkaz

Forecasts